Startseite Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome

  • Raf Brouns , Annick Wauters , Gerda Van De Vijver , Didier De Surgeloose , Rishi Sheorajpanday und Peter P. De Deyn
Veröffentlicht/Copyright: 18. Dezember 2009
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Although uric acid (UA) is one of the most important antioxidants in plasma and appears to be neuroprotective in animal models, results from human studies are controversial. In this study, we investigated the kinetics of serum UA concentrations in the acute, subacute and chronic phase of ischemic stroke and its relation with initial stroke severity, stroke evolution in the subacute phase and long-term stroke outcome.

Methods: Serum concentrations of UA were measured in 199 stroke patients at admission (median, 2.8 h after stroke onset), at 24 h, 72 h, day 7, month 1 and month 3 after onset of stroke. We evaluated the relationship between changes in UA concentrations and (a) stroke severity [patients with transient ischemic attack (TIA) vs. stroke patients, National Institutes of Health Stroke Scale (NIHSS) score at admission], (b) stroke evolution (stroke progression, infarct volume at 72 h), and (c) stroke outcome [modified Rankin scale (mRS) score at month 3, mortality].

Results: UA concentrations decreased significantly during the first 7 days after stroke onset before returning to baseline (p<0.001). Mean plasma UA concentrations decreased from 336.66±113.01 μmol/L at admission to 300.37±110.04 μmol/L at day 7 (p<0.001) in patients with stroke, but did not change significantly in patients with TIA. Changes in UA concentrations from admission to day 7 (ΔUAday 7) correlated with the NIHSS score (ρ=0.32; p<0.001), stroke progression (ρ=0.29; p=0.001), infarct volume (ρ=0.37; p<0.001), mRS score (ρ=0.28; p=0.001) and mortality (p=0.010).

Conclusions: Decreases in UA during the first week after onset of stroke correlates with more severe stroke, unfavorable stroke evolution, and poor long-term stroke outcome.

Clin Chem Lab Med 2010;48:383–90.


Corresponding author: Prof. Dr. Peter P. De Deyn, Laboratory of Neurochemistry and Behaviour, Institute of Born-Bunge, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium Phone: +32 3 265 26 20, Fax: +32 3 265 26 18,

Received: 2009-8-1
Accepted: 2009-10-19
Published Online: 2009-12-18
Published in Print: 2010-03-01

©2010 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Editorial
  2. Standardization of assays for clinically important enzymes that have high biologic variation: what is all the fuss about?
  3. Minireview
  4. Standardization in clinical enzymology: a challenge for the theory of metrological traceability
  5. Review
  6. Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?
  7. Opinion Paper
  8. The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for “normal” results
  9. Genetics and Molecular Diagnostics
  10. Integrated PCR amplification and detection processes on a Lab-on-Chip platform: a new advanced solution for molecular diagnostics
  11. Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility
  12. Association of the CD28/CTLA4/ICOS polymorphisms with susceptibility to rheumatoid arthritis
  13. Lack of association between DAZ gene methylation patterns and spermatogenic failure
  14. General Clinical Chemistry and Laboratory Medicine
  15. Evaluation of five routine glucose methods on an Olympus AU5400 analyzer using the CDC hexokinase reference method
  16. Multicentre evaluation of the Tosoh HbA1c G8 analyser
  17. Performance of a fully automated quantitative neopterin measurement assay in a routine voluntary blood donation setting
  18. Assay of oxidized fibrinogen reactivity (OFR) as a biomarker of oxidative stress in human plasma: the role of lysine analogs
  19. Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome
  20. Development and validation of a high performance liquid chromatography method to determine linezolid concentrations in pig pulmonary tissue
  21. Is heparin plasma suitable for the determination of B-type natriuretic peptide on the Beckman-Coulter Access 2?
  22. Composition of kidney stone fragments obtained after extracorporeal shock wave lithotripsy
  23. Reference Values and Biological Variations
  24. Gender does not influence cystatin C concentrations in healthy volunteers
  25. Stability of serum thyroid hormones following 8–11 years of cold storage
  26. Infectious Diseases
  27. Detection and quantitation of Epstein-Barr virus (EBV) DNA in EDTA whole blood samples using automated sample preparation and real time PCR
  28. Letters to the Editor
  29. The polymorphisms –1131T>C and the S19W of the APOA5 gene are not associated with coronary artery disease in a Brazilian population
  30. Tissue factor +5466A>G and –1208D>I genetic polymorphisms and severity of rheumatoid arthritis
  31. Ability of deferasirox to bind iron during measurement of iron
Heruntergeladen am 7.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.065/html?lang=de
Button zum nach oben scrollen